A B S T R A C T Vasopressin increased adenyl cyclase activity in homogenates of both inner and outer renal medulla of the rat. It also increased the concentration of cyclic 3',5'-adenosine monophosphate (AMP) in slices of both inner and outer medulla but not in renal cortex. In the inner medulla, a concentration of prostaglandin E1 (PGE1), which was ineffective by itself significantly reduced the stimulation of adenyl cyclase activity and cyclic AMP concentration induced by vasopressin. These results are consistent with the hypothesis that PGE1 can compete with vasopressin for adenyl cyclase-binding sites. However, the findings in the outer medulla suggest the situation is more complex. Although 10 M PGE1 had no effect by itself and inhibited the vasopressin-induced elevation of cyclic AMP, larger amounts of PGE1 increased both adenyl cyclase activity and cyclic AMP levels. The maximum effect on the latter parameter was at least 6 times as great as that of maximum amounts of vasopressin.
INTRODUCTION
It has been proposed that cyclic 3',5'-adenosine monophosphate (cyclic AMP)1 is the intracellular mediator of the physiological effects of vasopressin. This suggestion, first made by Orloff and Handler (1) , has received considerable experimental support. Vasopressin raises the concentration of cyclic AMP in the toad bladder (2) and increases the activity of adenyl cyclase in homogenates of the medulla of the rat kidney (3).
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Furthermore cyclic AMP, like vasopressin, increases water permeability and active sodium transport in the urinary bladder of the toad (1) and increases water permeability of the isolated perfused collecting duct of the rabbit (4).
Grantham and Orloff (5) observed that prostaglandin E1 (PGE1), by itself, increases the permeability of perfused collecting ducts to water but inhibits the effects of submaximal amounts of vasopressin. Although the effects of theophylline and PGE1 are additive, PGE1 does not influence the cyclic AMP-induced increases in water permeability of the collecting duct. To explain these observations, Grantham and Orloff proposed that PGE1 stimulated adenyl cyclase activity and increased production of cyclic AMP. Furthermore, by competing with vasopressin for receptors which influence adenyl cyclase, but being a less potent activator than vasopressin, PGE1 decreased vasopressinmediated increases in cyclic AMP production. This finding and this hypothesis were in general agreement with Bergstrom's proposal that prostaglandins might act as modulators of the adenyl cyclase reaction (6) . The present investigation was undertaken to evaluate further this concept by measuring the effects of vasopressin and PGE1, singly and in combination, on the concentration of cyclic AMP and on adenyl cyclase activity in the renal medulla.
METHODS
Male Sprague-Dawley rats weighing 140-250 g were sacrificed by decapitation. Tissue slices weighing 10-75 mg were prepared from outer red medulla, inner white medulla, or cortex using a Stadie-Riggs microtome. Slices were incubated for 15 min at 37°C in 2 ml Krebs-Ringer bicarbonate buffer containing 0.5 mg/ml glucose, 2 mg/ml albu- (9) . RESULTS Adenyl cyclasc activity. Vasopressin increased adenyl cyclase activity in both inner and outer medulla. Fig. 1 demonstrates the dose-response relationships between vasopressin concentration and adenyl cyclase activity in both the inner and outer medulla. In both significant increases were produced by 10' U/ml and 10' U/ml gave a maximal response.
PGE1 in concentrations as high as 10' M had no effect on adenyl cyclase activity in inner medulla but caused a significant increase in activity in the outer nmedulla (Table I ). In the inner medulla, the addition of 10-' M PGE1, which by itself had no effect on adenyl cyclase activity, together with a submaximal concentration of 10-' U/ml vasopressin, resulted in less of an increase in adenyl cyclase activity than was observed vith that amount of vasopressin alone (Table I ). The mean difference in 22 paired incubations between vasopressin alone and the combination was 14.0 ±5.0 (SE) l)mole cyclic AMP/mg protein per 15 min (P < 0.01).
Also noted in Table I is the fact that 10-' M PGE1 had no effect on concentrations of vasopressin as high as 5 X 102 U/ml. 1OV M PGE1 had no apparent effect on vasopressin, 10' U/ml, in the outer medulla. In a separate group of experiments in the outer medulla, control adenyl cyclase activity was 24.8 ±3.9 SE. Vasopressin 10' U/ml increased this value to 46.6 ±4.4 (P <0.01), but 10-M PGEL had no measurable effect 25.4 ±4.1. The adenyl cyclase activity with the com- (Figs. 2 and 3) . As with adenyl cyclase activity, vasopressin 10-' U/ml appeared to have submaximal effect in both inner and outer medulla. In the inner medulla PGE1 in concentrations as high as 10-' M had no measurable effect on cyclic AMP concentration (Table II) . In the outer medulla PGE1 increased cyclic AMP concentration, and as is apparent in Fig.  4 there was a dose-response relationship between the amount of PGE± added and the measured concentration of cyclic AMP. 10-M PGE, was the lowest concentration noted to effect tissue cyclic AMP concentration.
The highest concentration of PGE1 tested (10' M) raised tissue cyclic AMP concentration to 131.0 +410.8, a value over 6-fold the maximum amount measured with vasopressin in the outer medulla.
In the inner medulla 10-' M PGE1, which alone had no effect on cyclic AMP concentration, decreased the effect of submaximal vasopressin, 10-U/ml, to increase tissue cyclic AMP concentration, but had no effect on concentrations of vasopressin as high as 5 X 10' U/ml (Table III) . The combination of 10' M PGE±, which by itself increased cyclic AMP concentration in the outer medulla, and vasopressin 10-' U/ml increased cyclic AMP concentration more than vasopressin alone. However, 10' M PGE1, which by itself is ineffective, had an inhibitory effect on vasopressin, 10' U/ml. (Table III) .
In contrast with the effects of vasopressin in the renal medulla, this hormone had no effect on the renal cortex where the mean control cyclic AMP concentra-'A20 OUYTER MEDULLA 10 M ME, relationship beand cyclic AMP the inner medulla was below the sensitivity of their method (11). Chase and Aurbach studied hormonal effects on adenyl cyclase activity in cortex and medulla in vitro (3). The medulla was much more responsive to vasopressin while the cortex was much more sensitive to parathyroid hormone. In the present experiments vasopressin significantly increased adenyl cyclase activity and tissue concentration of cyclic AMP in inner and outer-medulla but had no effect on cyclic AMP concentration in cortex. These findings further support the concept of Orloff and Handler that the physiological actions of vasopressin on responsive epithelial structures are mediated by cyclic AMP (1) .
The prostaglandins influence the adenyl cyclase-cyclic AMP system in several tissues in various ways. PGE1 increased tissue cyclic AMP concentration in pituitary (12) and thyroid (13) but inhibited the effects of epinephrine on cyclic AMP concentration and free fatty acid mobilization from adipose tissue (14) . PGE1 increases the permeability of the isolated perfused collecting duct to water (5) . The PGE,-induced increases in adenyl cyclase activity and tissue cyclic AMP concentration in the outer medulla are consistent with this hydroosmotic effect of PGE, being mediated by the adenyl cyclase-cyclic AMP system. In the isolated collecting duct, PGE1 decreases the effect of vasopressin to augment water permeability (5) . The inhibition of vasopressin-induced increases in adenyl cyclase activity and cyclic AMP concentration in the inner medulla suggests that PGE1 inhibits the physiological effect of vasopressin by competing with vasopressin for adenyl cyclase re- ceptors. In addition, the inhibition of vasopressin-induced increases in cyclic AMP concentration by an amount of 1OM PGE1, which by itself had no effect on cyclic AMP concentration, is consistent with vasopressin-PGEi competition for adenyl cyclase receptors. It should be emphasized that the PGE1 inhibition of vasopressin-induced increases in adenyl cyclase activity and cyclic AMP concentration was not complete. The amount of increase in cyclic AMP concentration caused by vasopressin even in the presence of PGE1, may be sufficient to exert maximal physiological effect. Conversely, the PGE1 inhibition of the hydro-osmotic effect of vasopressin is not complete (5) . Providing these in vitro data have physiological significance all of these findings then support the Grantham and Orloff hypothesis with respect to both the mechanism of action of PGEi itself on the kidney and the means by which it interferes with the action of vasopressin. However, Grantham and Orloff also suggested PGE1 was a less potent activator of adenyl cyclase than vasopressin (5) . The observation that in outer medulla PGE1 caused as much as a 6-fold greater increase in cyclic AMP concentration than did maximal amounts of vasopressin does not indicate that PGE1 is less effective in stimulating adenyl cyclase than is vasopressin. In addition the combination of PGE1 in amounts which had an effect on cyclic AMP concentration with vasopressin, actually caused a greater increase in cyclic AMP concentration than did either agent alone. These findings suggest that in outer medulla PGE1 is either a more effective activator of adenyl cyclase or there are at least two species of adenyl cyclase receptors in the outer medulla. If the latter is true then at least one species of receptor might be responsive to PGE, but not to vasopressin, and the additive effects of vasopressin and PGE1
in the outer medulla might not be inconsistent with the Grantham-Orloff hypothesis (5).
